May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Yüksel Ürün: DESTINY-Breast09 – Enhertu plus Pertuzumab Outperforms THP
Apr 23, 2025, 06:34

Yüksel Ürün: DESTINY-Breast09 – Enhertu plus Pertuzumab Outperforms THP

Yüksel Ürün, Prof. Dr. Ankara University School of Medicine, Department of Medical Oncology, shared a post on X:

“DESTINY-Breast09 shows: Enhertu + Pertuzumab > THP
  • Significant PFS benefit.
  • Consistent across all subgroups.
  • Early OS trend favoring combo.
Is this anew era in 1st-line HER2+ met. Breast cancer?”

Read Further.

Yüksel Ürün: DESTINY-Breast09 - Enhertu plus Pertuzumab Outperforms THP